Radiosensitivity index as a predictive biomarker for radiotherapy de-intensification in nasopharyngeal carcinoma: abridged secondary publication

Hong Kong Med J. 2024 Feb;30 Suppl 1(1):27-28.

Authors

C L Chiang¹, W M A Lee¹, C W H Choi², K C R Ngan², W T Ng¹, H F V Lee¹, T C Lam¹, K O Lam¹, K C Tsang¹, W H J Wong³

Affiliations

¹ Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Division of Epidemiology and Biostatistics, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
³ School of Biomedical Science, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

PMID: 38413209

No abstract available

MeSH terms

Biomarkers
Carcinoma*
Cell Line, Tumor
Humans
Nasopharyngeal Carcinoma / radiotherapy
Nasopharyngeal Neoplasms* / radiotherapy
Radiation Tolerance

Substances

Biomarkers